Skip to main content

Table 4 Composition of media used in rMP1102 production assays

From: Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33

  Med-1 (Modified FM22) Med-2 Med-3 (BSM) Med-4 YPD BMGY
KH2PO4 42.9 4 6
H3PO4 26.7 ml
(NH4)2SO4 5 4
NH4H2PO4 50
CaSO4 0.6   0.93 0.4
CaCl2 0.38
K2SO4 14.3 18.2 18.2 20
MgSO4•7H2O 11.7 9.4 14.9 15
KOH 4.13 1.5
Citric acid 1.92
Glucose 40 40 40 40 40 40
Peptone 20 20
Yeast extract 10 10
PTM1 0.48% 0.48% 0.48% 0.48% 0.48% 0.48%
Reference [42] [35] [43] [16]